These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 8929238)
21. 5-HT4 receptor agonists enhance both cholinergic and nitrergic activities in human isolated colon circular muscle. Cellek S; John AK; Thangiah R; Dass NB; Bassil AK; Jarvie EM; Lalude O; Vivekanandan S; Sanger GJ Neurogastroenterol Motil; 2006 Sep; 18(9):853-61. PubMed ID: 16918765 [TBL] [Abstract][Full Text] [Related]
22. Modulation by 5-HT1A receptors of the 5-HT2 receptor-mediated tachykinin-induced contraction of the rat trachea in vitro. Germonpré PR; Joos GF; Pauwels RA Br J Pharmacol; 1998 Apr; 123(8):1571-8. PubMed ID: 9605563 [TBL] [Abstract][Full Text] [Related]
23. Neurokinin receptors (NK1, NK2) in the mouse: a pharmacological study. Nsa Allogho S; Nguyen-Le XK; Gobeil F; Pheng LH; Regoli D Can J Physiol Pharmacol; 1997 Jun; 75(6):552-7. PubMed ID: 9276127 [TBL] [Abstract][Full Text] [Related]
24. Effects of tachykinin receptor antagonists, FK224 and FK888, in a guinea-pig model of nasal allergy. Katahashi T; Konno A Rhinology; 1997 Jun; 35(2):63-6. PubMed ID: 9299653 [TBL] [Abstract][Full Text] [Related]
25. An antagonist of neurokinin A, but not substance P, activity on tracheal smooth muscle from guinea-pig. Shanab AA; Guthrie DJ; Irvine GB; Murphy RF; Walker B; Allen JM Biochem Soc Trans; 1990 Apr; 18(2):286-7. PubMed ID: 1696219 [No Abstract] [Full Text] [Related]
26. Vasopressin release from the rat hypothalamo-neurohypophysial system: effects of tachykinin NK-1 and NK-2 receptors agonists and antagonists. Juszczak M Neuro Endocrinol Lett; 2005 Aug; 26(4):367-72. PubMed ID: 16136007 [TBL] [Abstract][Full Text] [Related]
28. Effect of SR-140333, a neurokinin-1 receptor antagonist, on airway reactivity to methacholine in sedated rats. Tian J; Wei EQ; Chen JS; Zhang WP Zhongguo Yao Li Xue Bao; 1997 Nov; 18(6):485-8. PubMed ID: 10322900 [TBL] [Abstract][Full Text] [Related]
29. Neurokinin subtype receptors mediating substance P contraction in immature rabbit airways. Kazem E; John C; Tanaka DT Pediatr Res; 1996 Jan; 39(1):120-6. PubMed ID: 8825396 [TBL] [Abstract][Full Text] [Related]
30. Mechanisms mediating substance P-induced contraction in the rat iris in vitro. Grumann-Júnior A; Dias MA; Alves RV; Boteon JE; Calixto JB Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1861-70. PubMed ID: 10845610 [TBL] [Abstract][Full Text] [Related]
31. Substance P, neurokinins A and B, and synthetic tachykinin peptides protect mesencephalic dopaminergic neurons in culture via an activity-dependent mechanism. Salthun-Lassalle B; Traver S; Hirsch EC; Michel PP Mol Pharmacol; 2005 Nov; 68(5):1214-24. PubMed ID: 16077032 [TBL] [Abstract][Full Text] [Related]
32. Oxytocin release from the rat neurohypophysis into the blood: effects of tachykinin NK-1 and NK-2 receptors agonists and antagonists. Juszczak M; Boczek-Leszczyk E J Physiol Pharmacol; 2008 Sep; 59(3):553-62. PubMed ID: 18953097 [TBL] [Abstract][Full Text] [Related]
33. Pharmacological characterization of ZD6021: a novel, orally active antagonist of the tachykinin receptors. Rumsey WL; Aharony D; Bialecki RA; Abbott BM; Barthlow HG; Caccese R; Ghanekar S; Lengel D; McCarthy M; Wenrich B; Undem B; Ohnmacht C; Shenvi A; Albert JS; Brown F; Bernstein PR; Russell K J Pharmacol Exp Ther; 2001 Jul; 298(1):307-15. PubMed ID: 11408556 [TBL] [Abstract][Full Text] [Related]
34. Tachykinin receptor subtypes in the isolated guinea pig heart and their role in mediating responses to neurokinin A. Chang Y; Hoover DB; Hancock JC; Smith FM J Pharmacol Exp Ther; 2000 Jul; 294(1):147-54. PubMed ID: 10871306 [TBL] [Abstract][Full Text] [Related]
35. The tachykinins neurokinin A and substance P, but not neurokinin B, stimulate contraction of isolated muscle cells from rat small intestine. Lördal M; Hellström PM Acta Physiol Scand; 1999 May; 166(1):75-6. PubMed ID: 10372981 [No Abstract] [Full Text] [Related]
36. Effect of melatonin on the vasopressin secretion as influenced by tachykinin NK-1 receptor agonist and antagonist: in vivo and in vitro studies. Juszczak M; Boczek-Leszczyk E; Stempniak B J Physiol Pharmacol; 2007 Dec; 58(4):829-43. PubMed ID: 18195491 [TBL] [Abstract][Full Text] [Related]
37. Senktide-induced gerbil foot tapping behaviour is blocked by selective tachykinin NK1 and NK3 receptor antagonists. Sundqvist M; Kristensson E; Adolfsson R; Leffler A; Ahlstedt I; Engberg S; Drmota T; Sigfridsson K; Jussila R; de Verdier J; Novén A; Johansson A; Påhlman I; von Mentzer B; Lindström E Eur J Pharmacol; 2007 Dec; 577(1-3):78-86. PubMed ID: 17920583 [TBL] [Abstract][Full Text] [Related]
38. Neurokinin A and B: potent vasodilators in the canine forelimb. Dobbins DE; Buehn MJ; Dabney JM Microcirc Endothelium Lymphatics; 1990; 6(4-5):253-66. PubMed ID: 1704097 [TBL] [Abstract][Full Text] [Related]
39. Ava[L-Pro9,N-MeLeu10] substance P(7-11) (GR 73632) and Sar9, Met(O2)11 increase distention-induced peristalsis through activation of neurokinin-1 receptors on smooth muscle and interstitial cells of cajal. Nieuwmeyer F; Ye J; Huizinga JD J Pharmacol Exp Ther; 2006 Apr; 317(1):439-45. PubMed ID: 16330493 [TBL] [Abstract][Full Text] [Related]
40. Peptide-based tachykinin NK2 receptor antagonists. Quartara L; Rovero P; Maggi CA Med Res Rev; 1995 Mar; 15(2):139-55. PubMed ID: 7537837 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]